South Korea Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026
South Korea Pharmaceuticals Market @Summary, Competitive Analysis and Forecast to 2026
SUMMARY
Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The South Korean pharmaceuticals market had total revenues of $29.2 billion in 2021, representing a compound annual growth rate (CAGR) of 5.9% between 2016 and 2021.
- South Korea is currently being confronted with an aging population, which is likely to drive demand for pharmaceutical products due to increased incidence of age-associated medical issues, such as diabetes and cardiovascular disease.
- The South Korean pharmaceuticals market could benefit from increased public and private sector investment in emerging biotechnology companies with new and innovative products to offer.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in South Korea
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Korea
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the South Korea pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the South Korea pharmaceuticals market by value in 2021?
- What will be the size of the South Korea pharmaceuticals market in 2026?
- What factors are affecting the strength of competition in the South Korea pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in South Korea's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths and weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What impact is the COVID-19 pandemic having on the market?
8 COMPANY PROFILES
8.1. Chong Kun Dang Pharmaceutical Corporation
8.2. Daewoong Pharmaceutical Co Ltd
8.3. Hanmi Pharmaceuticals Co Ltd
8.4. Pfizer Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths and weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What impact is the COVID-19 pandemic having on the market?
8 COMPANY PROFILES
8.1. Chong Kun Dang Pharmaceutical Corporation
8.2. Daewoong Pharmaceutical Co Ltd
8.3. Hanmi Pharmaceuticals Co Ltd
8.4. Pfizer Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: South Korea pharmaceuticals market value: $ billion, 2016–21
Table 2: South Korea pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: South Korea pharmaceuticals market value forecast: $ billion, 2021–26
Table 4: South Korea pharmaceuticals market share: % share, by value, 2021
Table 5: Chong Kun Dang Pharmaceutical Corporation: key facts
Table 6: Chong Kun Dang Pharmaceutical Corporation: Annual Financial Ratios
Table 7: Chong Kun Dang Pharmaceutical Corporation: Key Employees
Table 8: Daewoong Pharmaceutical Co Ltd: key facts
Table 9: Daewoong Pharmaceutical Co Ltd: Annual Financial Ratios
Table 10: Daewoong Pharmaceutical Co Ltd: Key Employees
Table 11: Hanmi Pharmaceuticals Co Ltd: key facts
Table 12: Hanmi Pharmaceuticals Co Ltd: Annual Financial Ratios
Table 13: Hanmi Pharmaceuticals Co Ltd: Key Employees
Table 14: Pfizer Inc.: key facts
Table 15: Pfizer Inc.: Annual Financial Ratios
Table 16: Pfizer Inc.: Key Employees
Table 17: Pfizer Inc.: Key Employees Continued
Table 18: South Korea size of population (million), 2017–21
Table 19: South Korea gdp (constant 2005 prices, $ billion), 2017–21
Table 20: South Korea gdp (current prices, $ billion), 2017–21
Table 21: South Korea inflation, 2017–21
Table 22: South Korea consumer price index (absolute), 2017–21
Table 23: South Korea exchange rate, 2017–21
Table 1: South Korea pharmaceuticals market value: $ billion, 2016–21
Table 2: South Korea pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: South Korea pharmaceuticals market value forecast: $ billion, 2021–26
Table 4: South Korea pharmaceuticals market share: % share, by value, 2021
Table 5: Chong Kun Dang Pharmaceutical Corporation: key facts
Table 6: Chong Kun Dang Pharmaceutical Corporation: Annual Financial Ratios
Table 7: Chong Kun Dang Pharmaceutical Corporation: Key Employees
Table 8: Daewoong Pharmaceutical Co Ltd: key facts
Table 9: Daewoong Pharmaceutical Co Ltd: Annual Financial Ratios
Table 10: Daewoong Pharmaceutical Co Ltd: Key Employees
Table 11: Hanmi Pharmaceuticals Co Ltd: key facts
Table 12: Hanmi Pharmaceuticals Co Ltd: Annual Financial Ratios
Table 13: Hanmi Pharmaceuticals Co Ltd: Key Employees
Table 14: Pfizer Inc.: key facts
Table 15: Pfizer Inc.: Annual Financial Ratios
Table 16: Pfizer Inc.: Key Employees
Table 17: Pfizer Inc.: Key Employees Continued
Table 18: South Korea size of population (million), 2017–21
Table 19: South Korea gdp (constant 2005 prices, $ billion), 2017–21
Table 20: South Korea gdp (current prices, $ billion), 2017–21
Table 21: South Korea inflation, 2017–21
Table 22: South Korea consumer price index (absolute), 2017–21
Table 23: South Korea exchange rate, 2017–21
LIST OF FIGURES
Figure 1: South Korea pharmaceuticals market value: $ billion, 2016–21
Figure 2: South Korea pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: South Korea pharmaceuticals market value forecast: $ billion, 2021–26
Figure 4: Forces driving competition in the pharmaceuticals market in South Korea, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in South Korea, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in South Korea, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2021
Figure 10: South Korea pharmaceuticals market share: % share, by value, 2021
Figure 1: South Korea pharmaceuticals market value: $ billion, 2016–21
Figure 2: South Korea pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: South Korea pharmaceuticals market value forecast: $ billion, 2021–26
Figure 4: Forces driving competition in the pharmaceuticals market in South Korea, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in South Korea, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in South Korea, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2021
Figure 10: South Korea pharmaceuticals market share: % share, by value, 2021
